background: there is a controversy about the relation between anti-hepatitis b (anti-hbs) antibody level and obesity. we designed this study to compare the vaccine efficacy in obese/overweight and non-obese cases. methods: in this cross-sectional study, 242 obese/overweight and 85 non-obese individuals were participated. cases were selected from a referral clinic for obesity and a referral hepa...

background: health care workers (hcw) are at high risk of contracting various infectious diseases and play a dual role in the transmission of infections in health care facilities. objective: to determine the seroprotection against hepatitis b, measles, rubella, and varicella among hcws in a community hospital in qatar. methods: this is a cross-sectional survey conducted in a 75-bed community ho...

Manufacturing new Hepatitis B virus vaccines, specifically by the use of nanoparticles, is of high global interest. In this paper, a new biocompatible and biodegradable structure of nano-sized hepatitis B virus’ surface antigen (HBsAg) was generated by conjugation with dendrimers, a low cost biodegradable and biocompatible polymer. The physicochemical properties of the conjugate were characteri...

BACKGROUND Knowledge about the travel-associated risks of hepatitis A and B, and the extent of pre-travel health-advice being sought may vary between countries. METHODS An online survey was undertaken to assess the awareness, advice-seeking behaviour, rates of vaccination against hepatitis A and B and adherence rates in Australia, Finland, Germany, Norway, Sweden, the UK and Canada between Au...

Vaccination for hepatitis B virus (HBV) infection and treatment for chronic hepatitis B, while effective for primary prevention and control of the disease, still have their limitations. Global coverage of HBV immunization needs improvement. Several patient populations are noted to have suboptimal seroprotective rates after HBV vaccination. There are currently several potential new vaccines unde...

     Thimerosal, which is approximately 50% mercury by weight is a preservative widely used in vaccines since the 1930’s. It meets the requirements for a preservative as set forth by Pharmacopeia challenge test and has been shown to be effective against a broad spectrum of pathogens. In July 1999, the Public Health Service agencies and vaccine manufacturers agreed that thimerosal should be redu...

     Thimerosal, which is approximately 50% mercury by weight is a preservative widely used in vaccines since the 1930’s. It meets the requirements for a preservative as set forth by Pharmacopeia challenge test and has been shown to be effective against a broad spectrum of pathogens. In July 1999, the Public Health Service agencies and vaccine manufacturers agreed that thimerosal should be redu...

LEARNING OBJECTIVES After completion of this chapter individuals should be able to: 1 Define hepatitis and its symptomatology. 2 Distinguish between the various viruses associated with hepatitis. 3 Describe the general features of hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E, including the etiology, transmission, diagnosis, sequelae, and prophylaxis. 4 List and discuss th...

Background and aims: The frequency of chronic hepatitis B virus infection varies totally in different part of the world but it could be categorized as high, intermediate and low endimicity. In this regard, development of safe and effective vaccines against infectious diseases especially hepatitis B virus that are still required for emerging new pathogens, re-emerging old pathog...